Abstract
A retrospective assessment of clinical characteristics, complications/ associations, laboratory investigations, treatment modalities and outcome in an inceptional cohort of 22 (male-13) children with juvenile dermatomyositis (JDM) receiving treatment at Jaslok Hospital, Mumbai during 1997–2012 was performed. Mean age at diagnosis was 7.52 ± 3.99 years. Typical skin rash and muscle weakness were present in all children. Common complications included cutaneous ulcers (27.27%), dysphagia (22.72%) and calcinosis (18.18%).All patients presented with at least one of the serum muscle enzymes elevated. Absence of mortality and cardio-pulmonary complications and a monocyclic course in 72.7% of our patients are at variance from Western series.
Similar content being viewed by others
References
Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum. 2009;60:1825–1830.
Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344–347.
Singh S, Bansal A. Twelve years experience of juvenile dermatomyositis in north India. Rheumatol Int. 2006;26:510–515.
Mathiesen PR, Zak M, Herlin T, Nielsen SM. Disease patterns in Danish juvenile dermatomyositis patients. Pediatric Rheumatol. 2008;6:S17.
McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al. The juvenile dermatomyositis national registry and repository (UK and Ireland)-clinical characteristics of children recruited within the first 5 yr. Rheumatology. 2006; 45:1255–1260.
Sallum AM, Kiss MH, Sachetti S, Resende MB, Moutinho KC, Carvalho Mde S, et al. Juvenile dermatomyositis-Clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients. Arq Neuropsiquiatr 2002;60:889–899.
Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res. 2010;62:63–72.
Chowdhary V, Wakhlu A, Agarwal A, Misra R. Outcome in juvenile dermatomyositis. Indian Pediatr. 2002;39:931–935.
Shehata R, al-Mayouf S, al-Dalaan A, al-Mazaid A, al-Balaa S, Bahabri S. Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin Exp Rheumatol. 1999;17:115–118.
Hiketa T, Matsumoto Y, Ohashi M, Sasaki R. Juvenile dermatomyositis: a statistical study of 114 patients with dermatomyositis. J Dermatol. 1992;19:470–476.
Christensen ML, Pachman LM, Maryjowski MC. Antibody to Coksackie B virus: Increased incidence in sera from children with recently diagnosed juvenile dermatomyositis. Arthritis Rheum. 1983;26:824–829.
Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am. 2002;28:833–857.
Huber AM. Idiopathic inflammatory myopathies in childhood: current concepts. Pediatr Clin N Am. 2012;59:365–380.
Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, Pilkington CA. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatol. 2008;47:877–880.
Rider LG, Lindsley CB, Cassidy JT. Juvenile dermatomyositis. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB, editors. Textbook of pediatric rheumatology, 6th ed Philadelphia: Saunders; 2011. p. 375–413.
Huber AM, Lang B, Le Blanc CM, Birdi N, Bolaria RK, Malleson P, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis, Arthritis Rheum. 2000;43:541–549.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chickermane, P.R., Mankad, D. & Khubchandani, R.P. Disease patterns of juvenile dermatomyositis from western India. Indian Pediatr 50, 961–963 (2013). https://doi.org/10.1007/s13312-013-0260-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-013-0260-4